Renal oncocytoma with adverse pathologic features: a clinical and pathologic study of 50 cases

Khaleel I. Al-Obaidy,Liang Cheng

DOI: https://doi.org/10.1038/s41379-021-00849-z

IF: 8.209

2021-06-08

Modern Pathology

Abstract:Renal oncocytoma is the most common benign epithelial renal neoplasm. Several adverse features that would typically increase the stage of renal cell carcinomas are not uncommon in renal oncocytoma, including perinephric, sinus fat, or renal vein invasion. Herein, we report the largest single institutional series of renal oncocytoma with adverse pathologic features. The cohort comprised 50 patients, 38 were men (76%) and 12 were women (24%), with a mean age of 68 years (range, 50–87 years). All cases were diagnosed on nephrectomy specimens. No laterality predilection was noted. The tumors ranged in size from 1.5–15.7 cm (mean, 5.3 cm). Adverse pathologic features included perinephric fat invasion (<i>n</i> = 25; 50%), renal sinus fat invasion (<i>n</i> = 9; 18%), and renal vein invasion (<i>n</i> = 5; 10%). More than one adverse feature was seen in 11 tumors (22%). All tumors showed diffuse reactions to KIT (<i>n</i> = 40; 100%) and cyclin D1 (<i>n</i> = 27; 100%). Keratin 7 highlighted rare (&lt;5%) scattered cells, as well as entrapped renal tubules (<i>n</i> = 21; 100%). Reaction to DOG1 was patchy in three tumors (<i>n</i> = 27; 11%) while reactions to vimentin (<i>n</i> = 31) and Hale colloidal iron special stain (<i>n</i> = 30) were negative. On follow-up, no tumor recurrence or metastasis was observed over a follow-up range of 1–144 months (mean, 54 months; median, 60 months). Our data suggest that adverse pathologic features in renal oncocytoma do not alter their benign course.

pathology